Detection of dysregulated protein-association networks by high-throughput proteomics predicts cancer vulnerabilities

Multiplexed mass spectrometry analysis of breast cancer cell lines uncovers co-regulation of protein abundance that predicts the vulnerabilities of different cancers to drugs.